Urology
Volume 68, Issue 2, Supplement , Pages 1-2 , August 2006

Introduction

  • Linda Brubaker

      Affiliations

    • Departments of Obstetrics, Gynecology, and Urology, Loyola University Medical Center, Maywood, Illinois, USA
    • Corresponding Author InformationReprint requests: Linda Brubaker, MD, MS, Departments of Obstetrics, Gynecology, and Urology, Loyola University Medical Center, 2160 South First Avenue, Building 103, Room 1004D, Maywood, Illinois 60153.
    • Linda Brubaker receives research funding from Q-Med, Pfizer Inc, and Allergan and receives consultant/speaker honoraria from Q-Med, Novartis, Pfizer Inc, and Astellas.
    • ,
  • Christopher Chapple

      Affiliations

    • Department of Urology Research, Royal Hallamshire Hospital, Sheffield, United Kingdom
    • Christopher Chapple is a scientific consultant to Pfizer Inc, Astellas, Novartis, Schwarz, Q-Med, Tanabe, and Allergan; and receives funding from Pfizer and Allergan.

References 

  1. Abrams P , Cardozo L , Fall M , et al.   The standardisation of terminology in lower urinary tract function (report from the standardisation sub-committee of the International Continence Society) . Urology . 2003;61:37–49
  2. Wiklund I . Assessment of patient-reported outcomes in clinical trials (the example of health-related quality of life) . Fundam Clin Pharmacol . 2004;18:351–363
  3. Chapple C , Khullar V , Gabriel Z , et al.   The effects of antimuscarinic treatments in overactive bladder (a systematic review and meta-analysis) . Eur Urol . 2005;48:5–26

PII: S0090-4295(06)00775-8

doi: 10.1016/j.urology.2006.01.092

Urology
Volume 68, Issue 2, Supplement , Pages 1-2 , August 2006

Article Tools